Compositions and methods of treating glaucoma
AssigneeOrasis
InventorRichard A. Hill
Life of this patent
Estimating the term…
Abstract
Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.
Claims19
A method of lowering intraocular pressure comprising administering a therapeutically effective amount of an amphipathic compound or pharmaceutically acceptable derivative thereof to a subject in need of such treatment.
A method of lowering intraocular pressure comprising administering a therapeutically effective amount of an enzyme or enzymatically active fragment thereof having an enzymatic activity of forming an amphipathic compound or pharmaceutically acceptable derivative thereof to a subject in need of such treatment.
A method of maintaining a target intraocular pressure, comprising:
- measuring a baseline intraocular pressure of a subject;
- determining the target intraocular pressure for the subject;
- selecting a first therapeutic compound which generally decreases intraocular pressure by an amount about the difference between the baseline intraocular pressure and the target intraocular pressure;
- administering the first therapeutic compound;
- measuring the intraocular pressure of the subject after administration of the compound;
- selecting a second therapeutic compound which decreases the intraocular pressure by an amount different than that of the first therapeutic compound if the intraocular pressure after administration is not about the target intraocular pressure;
- and
- administering the second therapeutic compound.
A drug screening method comprising:
- preparing a donor eye tissue;
- introducing fluid into an anterior segment of the donor eye tissue;
- introducing a candidate therapeutic molecule into the anterior segment of the donor eye tissue;
- and
- determining a measurement related to the introduction of the candidate therapeutic molecule into the anterior segment of the donor eye tissue.
Dependencies are inferred from the claim text.